| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9df90d7822cc480ce12c480f4089e229 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 |
| filingDate |
2003-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_156dc671b47d925bd458029d1d527a29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9914a93ec28c193057ae70d61aedc88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0867be04069728abdca5a16fd27170b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86daeb31cd42161ec8040e4273d5013b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2669ae10ccccfc55e4833c23abb931a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38d50491bdcdac1e847b9d9ad8e72fe6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8094cd3b07e90a5fac02da819154f0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1932093b93caedb08bcfa5c1c401f310
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3b8db7bbd51fb00e161de6ab41831f6 |
| publicationDate |
2004-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2004002350-A |
| titleOfInvention |
Monoclonal antibody, hybridoma, cell isolation method, isolated cells, immunological diagnostics |
| abstract |
The present invention provides a novel monoclonal antibody that can efficiently separate neural stem cells and progenitor cells by selectively recognizing neural stem cells and progenitor cells. The present invention has a property of selectively recognizing an antigen expressed in cells located in the ependymal layer and the ependymal lower layer region of a human brain tissue. It is a monoclonal antibody capable of selectively immunostaining the lower region of the ependymal layer. By selectively recognizing cells other than neural stem cells and progenitor cells among brain nerve cells, neural stem cells and progenitor cells can be efficiently separated from human brain tissue. Since cells other than neural stem cells and progenitor cells are selectively recognized, a fluorescent substance is not deposited on target stem cells or progenitor cells, so that safety of the isolated stem cells or progenitor cells can be ensured. [Selection diagram] None |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010057511-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010060576-A |
| priorityDate |
2002-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |